CRSP: the cash flow

MyFinsight

For the year ending 2025-12-31, CRSP had $49,302K increase in cash & cash equivalents over the period. -$345,928K in free cash flow.

Cash Flow	2025-12-31
Net loss	-581,599
Depreciation and amortization	19,479
Stock-based compensation expense	72,499
Other non-cash items, net	23,528
Acquired in-process research and development	96,253
Accounts receivable	-25,000
Prepaid expenses and other assets	-3,337
Accounts payable and accrued expenses	44,894
Deferred revenue	-397
Operating lease assets and liabilities	-5,210
Other liabilities, net	4,258
Net cash used in operating activities	-345,014
Purchase of property, plant and equipment	914
Purchase of in-process research and development	25,000
Investment in equity securities	9,700
Sale of equity securities	702
Purchases of marketable debt securities	1,008,170
Maturities of marketable debt securities	1,011,277
Net cash used in (provided by) investing activities	-31,805
Proceeds from issuance of common shares, net of issuance costs	398,090
Proceeds from exercise of options and espp contributions, net of issuance costs	27,936
Net cash provided by financing activities	426,026
Effect of exchange rate changes on cash	95
Increase (decrease) in cash	49,302
Cash and cash equivalents at beginning of period	309,776
Cash and cash equivalents at end of period	359,078

Unit: Thousand (K) dollars (except for numbers of shares and EPS).